Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II irinotecan + cisplatin as first-line therapy for advanced gastric cancer
ChiCTR-TNC-11001549Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan and cisplatin in gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: overall response rate. Started Jul 2011; status: completed.
02
Drugs
irinotecancisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-TNC-11001549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001549.